Direkt zum Inhalt
Merck
  • Anticoagulant carryover may influence clot formation in direct tube coagulase tests from blood cultures.

Anticoagulant carryover may influence clot formation in direct tube coagulase tests from blood cultures.

Journal of clinical microbiology (2005-09-08)
Kerry Varettas, Chinmoy Mukerjee, Peter C Taylor
ZUSAMMENFASSUNG

The tube coagulase test (TCT) performed directly from positive blood culture bottles has been used to reduce the turnaround time for identifying Staphylococcus aureus. Most reports have shown the test to be specific but often lacking sufficient sensitivity to be useful. In a prospective study of blood culture bottles (BCB) signaling positive, with a Gram-stained smear showing gram-positive cocci resembling staphylococci, the sensitivity of the direct TCT was improved by diluting the BCB broth 1:10 in saline before inoculating 0.1 ml into 1.0 ml of 10% pooled human plasma. It was hypothesized that the improved sensitivity might be explained by reduced carryover of the anticoagulant sodium polyanetholesulfonate (SPS) used in blood culture media. By titrating the inoculum size and the concentration of SPS in an in vitro checkerboard assay, it was shown that concentrations of SPS >0.0008% prevented plasma coagulation. The 1:10 dilution of blood culture broth reduced the amount of residual SPS carried over to the TCT to a level (0.0005%) that did not impair plasma coagulation. The direct TCT inoculated with a 1:10 saline dilution of blood culture broth achieved 100% specificity and sensitivity within 4 h of inoculation without reducing the quality or quantity of coagulum.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Polyanetholsulfonsäure Natriumsalz, powder
Sigma-Aldrich
Polyanetholsulfonsäure Natriumsalz
Sigma-Aldrich
Polyanetholsulfonsäure Natriumsalz, BioUltra